1,282
Views
2
CrossRef citations to date
0
Altmetric
Research Paper

Role of long non-coding RNA-adducin 3 antisense RNA1 in liver fibrosis of biliary atresia

ORCID Icon, , ORCID Icon, & ORCID Icon
Pages 6222-6230 | Received 27 Nov 2021, Accepted 08 Feb 2022, Published online: 04 Mar 2022

References

  • Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet. 2009;374(9702):1704–1713.
  • Muraji T, Ohtani H, Ieiri S. Unique manifestations of biliary atresia provide new immunological insight into its etiopathogenesis. Pediatr Surg Int. 2017;33(12):1249–1253.
  • Sokol RJ, Mack C. Etiopathogenesis of biliary atresia. Semin Liver Dis. 2001;21(4):517–524.
  • Lampela H, Pakarinen M. [Biliary atresia]. Duodecim. 2013;129(14):1485–1493.
  • Lakshminarayanan B, Davenport M. Biliary atresia: a comprehensive review. J Autoimmun. 2016;73:1–9.
  • Nizery L, Chardot C, Sissaoui S, et al. Biliary atresia: clinical advances and perspectives. Clin Res Hepatol Gastroenterol. 2016;40(3):281–287.
  • Parsons CJ, Takashima M, Rippe RA. Molecular mechanisms of hepatic fibrogenesis. J Gastroenterol Hepatol. 2007;22(1):S79–84.
  • Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology. 2008;134(6):1655–1669.
  • Peng H, Wan L-Y, Liang -J-J, et al. The roles of lncRNA in hepatic fibrosis. Cell Biosci. 2018;8:63.
  • He Z, Yang D, Fan X, et al. The roles and mechanisms of lncRNAs in liver fibrosis. Int J Mol Sci. 2020;21(4):1482.
  • Makhmudi A, Kalim AS, Gunadi. microRNA-21 expressions impact on liver fibrosis in biliary atresia patients. BMC Res Notes. 2019;12(1):189.
  • Schmitt AM, Chang HY. Long noncoding RNAs in cancer pathways. Cancer Cell. 2016;29(4):452–463.
  • Yu F, Zheng J, Mao Y, et al. Long non-coding RNA APTR promotes the activation of hepatic stellate cells and the progression of liver fibrosis. Biochem Biophys Res Commun. 2015;463(4):679–685.
  • Makhmudi A, Supanji R, Putra BP, et al. The effect of APTR, Fn14 and CD133 expressions on liver fibrosis in biliary atresia patients. Pediatr Surg Int. 2020;36(1):75–79.
  • Zheng J, Dong P, Mao Y, et al. lincRNA-p21 inhibits hepatic stellate cell activation and liver fibrogenesis via p21. FEBS J. 2015;282(24):4810–4821.
  • Tu X, Zhang Y, Zheng X, et al. TGF-beta-induced hepatocyte lincRNA-p21 contributes to liver fibrosis in mice. Sci Rep. 2017;7(1):2957.
  • Wu G, Cai J, Han Y, et al. LincRNA-p21 regulates neointima formation, vascular smooth muscle cell proliferation, apoptosis, and atherosclerosis by enhancing p53 activity. Circulation. 2014;130(17):1452–1465.
  • Zhang QQ, Xu MY, Qu Y, et al. TET3 mediates the activation of human hepatic stellate cells via modulating the expression of long non-coding RNA HIF1A-AS1. Int J Clin Exp Pathol. 2014;7(11):7744–7751.
  • Li XQ, Ren ZX, Li K, et al. Key anti-fibrosis associated long noncoding rnas identified in human hepatic stellate cell via transcriptome sequencing analysis. Int J Mol Sci. 2018;19(3):675.
  • Garcia-Barcelo MM, Yeung M-Y, Miao X-P, et al. Genome-wide association study identifies a susceptibility locus for biliary atresia on 10q24.2. Hum Mol Genet. 2010;19(14):2917–2925.
  • Cheng G, Tang CS-M, Wong EH-M, et al. Common genetic variants regulating ADD3 gene expression alter biliary atresia risk. J Hepatol. 2013;59(6):1285–1291.
  • Tsai EA, Grochowski CM, Loomes KM, et al. Replication of a GWAS signal in a Caucasian population implicates ADD3 in susceptibility to biliary atresia. Hum Genet. 2014;133(2):235–243.
  • Tang V, Cofer ZC, Cui S, et al. Loss of a candidate biliary atresia susceptibility gene, add3a, causes biliary developmental defects in Zebrafish. J Pediatr Gastroenterol Nutr. 2016;63(5):524–530.
  • Ye Y, Li Z, Feng Q, et al. Downregulation of microRNA-145 may contribute to liver fibrosis in biliary atresia by targeting ADD3. PLoS One. 2017;12(9):e0180896.
  • Laochareonsuk W, Chiengkriwate P, Sangkhathat S. Single nucleotide polymorphisms within Adducin 3 and Adducin 3 antisense RNA1 genes are associated with biliary atresia in Thai infants. Pediatr Surg Int. 2018;34(5):515–520.
  • Wang X, Sun H, Zhu S. Long non-coding RNA PTAR inhibits apoptosis but promotes proliferation, invasion and migration of cervical cancer cells by binding miR-101. Bioengineered. 2021;12(1):4536–4545.
  • Aydin MM, Akcali KC. Liver fibrosis. Turk J Gastroenterol. 2018;29(1):14–21.
  • Bates MD, Bucuvalas J, Alonso M, et al. Biliary atresia: pathogenesis and treatment. Semin Liver Dis. 1998;18(3):281–293.
  • Zeng S, Sun P, Chen Z, et al. Association between single nucleotide polymorphisms in the ADD3 gene and susceptibility to biliary atresia. PLoS One. 2014;9(10):e107977.
  • Kaewkiattiyot S, Honsawek S, Vejchapipat P, et al. Association of X-prolyl aminopeptidase 1 rs17095355 polymorphism with biliary atresia in Thai children. Hepatol Res. 2011;41(12):1249–1252.
  • Zheng S, Guo Y, Dai L, et al. Long intergenic noncoding RNA01134 accelerates hepatocellular carcinoma progression by sponging microRNA-4784 and downregulating structure specific recognition protein 1. Bioengineered. 2020;11(1):1016–1026.
  • Zhou Y, Li K, Zou X, et al. LncRNA DHRS4-AS1 ameliorates hepatocellular carcinoma by suppressing proliferation and promoting apoptosis via miR-522-3p/SOCS5 axis. Bioengineered. 2021;12(2):10862–10877.